Chatsworth, CA, United States
D.B.P. Distribution recalls
1 recall recorded since 2018, most recently on 23 April 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)1
Terminated Class I Drugs
- Recall started
- 23 April 2019
- Terminated
- 7 March 2023
- Reason
- Marketed without an approved NDA/ANDA: undeclared sildenafil and tadalafil.
- Distribution
- Nationwide.
- Initiated
- Voluntary: Firm initiated
- Recall number
- D-1292-2019
- Titanium 4000, capsule, 4000 mg, 1 count blister card, 30 blister display boxt, distributed by Titanium 4000 UPC 86077000020
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.